CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children

Pediatric Infectious Disease Journal

Volumn 29, Issue 10, 2010, Pages 966-968

  Wongsawat, Jurai ^a   Puthanakit, Thanyawee ^b,c   Kanjanavanit, Suparat ^d   Hansudewechakul, Rawiwan ^e   Ngampiyaskul, Chaiwat ^f   Kerr, Stephen J ^b,g   Ubolyam, Sasiwimol ^b   Suwanlerk, Tulathip ^b   Kosalaraksa, Pope ^h   Luesomboon, Wicharn ⁱ   Ngo Giang Huong, Nicole ^j   Chandara, Mom ^k,l   Saphonn, Vonthanak ^k,l   Ruxrungtham, Kiat ^b,c   Ananworanich, Jintanat ^b,c,g  

^a Bamrasnaradura Infectious Disease Institute   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d NAKORNPING HOSPITAL   (Thailand)

^e Chiangrai Regional Hospital   (Thailand)

^f PRAPOKKLAO HOSPITAL   (Thailand)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h KHON KAEN UNIVERSITY   (Thailand)

ⁱ Queen Savang Vadhana Memorial Hospital   (Thailand)

^j IRD U174 Program for HIV Prevention and Treatment   (Thailand)

^k National Pediatric Hospital   (Cambodia)

^l Social Health Clinic   (Cambodia)

more..

Author keywords

antiretroviral treatment; ART initiation; Asia; CD4; children; HIV; WHO

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77957265160     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e0554c     Document Type: Article

References (10)

1. AIDS EPIDEMIC UPDATE 2009. Available at: http://data.unaids.org/pub/ Report/2009/JC1700-Epi-Update-2009-en.pdf. Accessed February 6, 2009.
2. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a metaanalysis. Lancet. 2003;362:1605-1611. (Pubitemid 37443527)
3. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIVinfected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
4. WHO Antiretroviral Therapy for Infants and Children 2008. Report of the WHO Technical References Group, Pediatric HIV/ART Care Guideline Group Meeting 10-12 April 2008. Available at: www.who.int/hiv/pub/paediatric/WHO-Paediatric- ART-guideline-rev-mreport-2008.pdf.
5. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection-February 23, 2009. Available at: http://www.aidsinfo.nih.gov/ contentfiles/PediatricGuidelines.pdf. Accessed August 17, 2009.
6. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. Available at: http://www.pentatrials.org/guide09.pdf. Accessed August 31, 2009.
7. World Health Organization. CD4 T-cell enumeration tech-nologies. Technical information. Available at: http://www.who.int/diagnostics
8. Dunn D, Woodburn P, Duong T, et al. Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis. 2008;197:398-404. (Pubitemid 351263421)
9. HIV Paediatric Prognostic Markers Collaboration Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS. 2006;20:1289-1294.
10. World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Available at: http://www.who.int/entity/ hiv/pub/arv/advice/en/index.html. Accessed January 2010.